Sanofi (MX:SNYN) — Stock Price
Sanofi (MX:SNYN) is currently trading at MX$746.30 MXN, up 0.72% today. Over the past 52 weeks, shares have ranged between MX$730.00 and MX$955.00. This page tracks Sanofi's live share price on the MX exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Sanofi.
Sanofi (SNYN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Sanofi's daily closing share price and trading volume on the MX exchange over the past year, giving a clear view of recent price momentum and liquidity.
Sanofi Income Statement — Revenue, Profit & Earnings by Year
Sanofi's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | MX$46.72 Billion | MX$44.29 Billion | MX$41.62 Billion | MX$45.39 Billion | MX$39.17 Billion |
| Cost of Revenue | MX$13.05 Billion | MX$13.21 Billion | MX$12.63 Billion | MX$13.70 Billion | MX$12.26 Billion |
| Gross Profit | MX$33.67 Billion | MX$31.08 Billion | MX$28.99 Billion | MX$31.69 Billion | MX$26.92 Billion |
| Research & Development | MX$7.84 Billion | MX$7.39 Billion | MX$6.51 Billion | MX$6.71 Billion | MX$5.69 Billion |
| SG&A | MX$10.24 Billion | MX$9.82 Billion | MX$9.48 Billion | MX$10.49 Billion | MX$9.55 Billion |
| Total Operating Expenses | MX$37.12 Billion | MX$35.36 Billion | MX$32.93 Billion | MX$33.51 Billion | MX$30.03 Billion |
| Operating Income | MX$9.60 Billion | MX$8.92 Billion | MX$8.69 Billion | MX$11.88 Billion | MX$9.15 Billion |
| EBITDA | — | — | — | MX$10.76 Billion | MX$9.75 Billion |
| EBIT | — | — | — | MX$11.04 Billion | MX$8.56 Billion |
| Interest Expense | MX$626.00 Million | MX$704.00 Million | MX$643.00 Million | MX$440.00 Million | MX$403.00 Million |
| Income Before Tax | MX$6.17 Billion | MX$6.70 Billion | MX$6.25 Billion | MX$8.27 Billion | MX$7.80 Billion |
| Income Tax Expense | — | — | — | MX$2.01 Billion | MX$1.56 Billion |
| Net Income | MX$7.81 Billion | MX$5.56 Billion | MX$5.40 Billion | MX$6.72 Billion | MX$6.22 Billion |
Sanofi Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Sanofi's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | MX$126.81 Billion | MX$132.80 Billion | MX$126.46 Billion | MX$124.58 Billion | MX$120.24 Billion |
| Total Current Assets | MX$30.95 Billion | MX$42.59 Billion | MX$30.67 Billion | MX$34.11 Billion | MX$30.65 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | MX$810.00 Million | MX$486.00 Million | MX$270.00 Million | MX$664.00 Million | MX$1.05 Billion |
| Net Receivables | MX$8.41 Billion | MX$7.68 Billion | MX$8.43 Billion | MX$8.42 Billion | MX$7.57 Billion |
| Inventory | MX$10.21 Billion | MX$9.43 Billion | MX$9.67 Billion | MX$8.96 Billion | MX$8.71 Billion |
| Property, Plant & Equipment | — | — | — | MX$11.68 Billion | MX$11.98 Billion |
| Goodwill | MX$41.30 Billion | MX$43.38 Billion | MX$49.40 Billion | MX$49.89 Billion | MX$48.06 Billion |
| Total Liabilities | MX$55.09 Billion | MX$54.94 Billion | MX$52.11 Billion | MX$51.07 Billion | MX$51.21 Billion |
| Total Current Liabilities | MX$28.34 Billion | MX$29.16 Billion | MX$24.21 Billion | MX$23.97 Billion | MX$21.30 Billion |
| Long-term Debt | MX$14.25 Billion | MX$11.79 Billion | MX$14.35 Billion | MX$14.86 Billion | MX$17.12 Billion |
| Net Debt | MX$10.93 Billion | MX$8.56 Billion | MX$7.68 Billion | MX$6.29 Billion | MX$10.21 Billion |
| Total Stockholder Equity | MX$71.38 Billion | MX$77.51 Billion | MX$74.04 Billion | MX$73.14 Billion | MX$68.68 Billion |
| Retained Earnings | — | — | — | — | — |
Sanofi Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Sanofi generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | MX$10.75 Billion | MX$9.08 Billion | MX$10.26 Billion | MX$10.53 Billion | MX$10.52 Billion |
| Capital Expenditures | MX$3.54 Billion | MX$3.19 Billion | MX$3.02 Billion | MX$1.61 Billion | MX$1.48 Billion |
| Free Cash Flow | MX$7.21 Billion | MX$5.89 Billion | MX$7.23 Billion | MX$8.32 Billion | MX$8.48 Billion |
| Investing Cash Flow | — | — | — | MX$-2.08 Billion | MX$-7.30 Billion |
| Financing Cash Flow | MX$-8.16 Billion | MX$-5.75 Billion | MX$-8.05 Billion | MX$-5.82 Billion | MX$-7.06 Billion |
| Dividends Paid | MX$-4.77 Billion | MX$4.70 Billion | MX$4.45 Billion | MX$4.17 Billion | MX$4.01 Billion |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | MX$5.68 Billion | MX$3.59 Billion | MX$4.79 Billion | MX$3.37 Billion | MX$3.00 Billion |
| Change in Cash | MX$216.00 Million | MX$-1.27 Billion | MX$-4.03 Billion | MX$2.64 Billion | MX$-3.82 Billion |
Sanofi Earnings History — EPS Actual vs. Analyst Estimates
Track Sanofi's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 30, 2026 | — | 1.13 | — |
| Apr 23, 2026 | — | 1.03 | — |
| Jan 29, 2026 | — | 0.81 | — |
| Oct 24, 2025 | — | 1.58 | — |
| Jul 31, 2025 | — | 1.00 | — |
| Apr 24, 2025 | — | — | — |